Total Payments
$123,630
2024 Payments
$5,254
Companies
59
Transactions
1,039
Medicare Patients
10,853
Medicare Billing
$772,996
Payment Breakdown by Category
Other$94,250 (76.2%)
Food & Beverage$18,717 (15.1%)
Consulting$6,559 (5.3%)
Travel$4,014 (3.2%)
Education$90.63 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $94,250 | 49 | 76.2% |
| Food and Beverage | $18,717 | 964 | 15.1% |
| Consulting Fee | $6,559 | 9 | 5.3% |
| Travel and Lodging | $4,014 | 11 | 3.2% |
| Education | $90.63 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $36,565 | 117 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $35,451 | 127 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $31,856 | 161 | $0 (2024) |
| PFIZER INC. | $4,718 | 52 | $0 (2024) |
| ARALEZ PHARMACEUTICALS US INC. | $4,292 | 8 | $0 (2018) |
| Boston Scientific Corporation | $1,393 | 80 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,153 | 86 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $903.11 | 41 | $0 (2024) |
| Amgen Inc. | $804.50 | 60 | $0 (2024) |
| Medtronic Vascular, Inc. | $572.72 | 18 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,254 | 85 | AstraZeneca Pharmaceuticals LP ($4,124) |
| 2023 | $6,673 | 130 | AstraZeneca Pharmaceuticals LP ($4,602) |
| 2022 | $14,696 | 150 | E.R. Squibb & Sons, L.L.C. ($8,290) |
| 2021 | $16,751 | 165 | AstraZeneca Pharmaceuticals LP ($8,810) |
| 2020 | $13,759 | 109 | AstraZeneca Pharmaceuticals LP ($12,662) |
| 2019 | $7,892 | 110 | E.R. Squibb & Sons, L.L.C. ($5,757) |
| 2018 | $13,605 | 125 | Novartis Pharmaceuticals Corporation ($5,449) |
| 2017 | $45,001 | 165 | Novartis Pharmaceuticals Corporation ($25,623) |
All Payment Transactions
1,039 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $2.48 | General |
| Category: Cardiovascular | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $2.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $9.87 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $3.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: DIABETES | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $11.53 | General |
| Category: Cardiovascular | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $1.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $20.06 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/25/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $15.15 | General |
| Category: Medical Device | ||||||
| 09/19/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: AVVIGO_IC | ||||||
| 09/18/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $58.60 | General |
| Category: LUX-Dx_CRM | ||||||
| 09/16/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/12/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Lithoplasty | ||||||
| 09/05/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $13.17 | General |
| Category: Medical Device | ||||||
| 08/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.59 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,654 | 3,249 | $1.6M | $172,608 |
| 2022 | 21 | 2,631 | 3,179 | $1.6M | $187,698 |
| 2021 | 24 | 2,818 | 3,526 | $1.3M | $215,617 |
| 2020 | 26 | 2,750 | 3,319 | $680,044 | $197,073 |
Total Patients
10,853
Total Services
13,273
Medicare Billing
$772,996
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 491 | 667 | $554,583 | $61,918 | 11.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 217 | 274 | $162,516 | $17,961 | 11.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 108 | 118 | $148,706 | $15,448 | 10.4% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 27 | 28 | $104,551 | $13,072 | 12.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 106 | 170 | $80,951 | $10,723 | 13.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 54 | 54 | $97,316 | $10,278 | 10.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 678 | 819 | $80,773 | $9,346 | 11.6% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 27 | 28 | $65,914 | $8,293 | 12.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $61,964 | $7,222 | 11.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 20 | 31 | $63,335 | $5,489 | 8.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 610 | 727 | $38,141 | $4,515 | 11.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 24 | $27,436 | $2,380 | 8.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 36 | 36 | $15,579 | $1,922 | 12.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 103 | 109 | $37,356 | $1,123 | 3.0% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 17 | 18 | $8,095 | $1,022 | 12.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $8,172 | $791.96 | 9.7% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 21 | 21 | $2,778 | $344.40 | 12.4% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 21 | 21 | $2,505 | $319.62 | 12.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 18 | 18 | $2,408 | $261.90 | 10.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 18 | 18 | $1,592 | $178.29 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 496 | 675 | $569,501 | $64,353 | 11.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 223 | 286 | $171,398 | $19,579 | 11.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 114 | 125 | $157,329 | $19,568 | 12.4% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 31 | 33 | $121,651 | $16,324 | 13.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 116 | 204 | $92,344 | $12,064 | 13.1% |
About Dr. Jay Stone, MD
Dr. Jay Stone, MD is a Interventional Cardiology healthcare provider based in Toms River, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1710961024.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Stone, MD has received a total of $123,630 in payments from pharmaceutical and medical device companies, with $5,254 received in 2024. These payments were reported across 1,039 transactions from 59 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($94,250).
As a Medicare-enrolled provider, Stone has provided services to 10,853 Medicare beneficiaries, totaling 13,273 services with total Medicare billing of $772,996. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Toms River, NJ
- Active Since 11/30/2005
- Last Updated 06/07/2012
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1710961024
Products in Payments
- ELIQUIS (Drug) $39,885
- FARXIGA (Drug) $33,907
- ENTRESTO (Drug) $31,550
- ZONTIVITY (Drug) $4,292
- BRILINTA (Drug) $1,366
- XARELTO (Drug) $1,153
- LifeVest (Device) $903.11
- Repatha (Biological) $520.62
- Vascepa (Drug) $477.14
- WATCHMAN (Device) $420.89
- JARDIANCE (Drug) $313.76
- LEQVIO (Drug) $305.96
- VERQUVO (Drug) $304.86
- Corlanor (Drug) $283.88
- PRALUENT (Drug) $280.37
- Resolute (Device) $272.75
- COMET (Device) $240.70
- OptoWire (Device) $228.92
- MYNX CONTROL (Device) $226.46
- VYNDAQEL (Drug) $208.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Toms River
Dr. Jasrai Gill, Md Mba, MD MBA
Interventional Cardiology — Payments: $28,069
Interventional Cardiology $28,069
Dr. Mohammed Usman, Md, MD
Interventional Cardiology — Payments: $17,033
Interventional Cardiology $17,033
Rakesh Gupta, M.d, M.D
Interventional Cardiology — Payments: $7,441
Interventional Cardiology $7,441
Dr. Parag Patel, M.d, M.D
Interventional Cardiology — Payments: $6,143
Interventional Cardiology $6,143
Ms. Anemona Anghel-Filip, Md, MD
Interventional Cardiology — Payments: $4,322
Interventional Cardiology $4,322